Articles tagged with Chronic Pain
A new clinical trial aims to test personalized brain stimulation targeting two pain-related brain networks for patients with severe, treatment-resistant central neuropathic pain. Researchers will use functional MRI to map each participant's brain and adjust stimulation settings based on individual responses.
Bone complications in sickle cell disease include early-onset osteoporosis, compression fractures, and avascular necrosis. Research aims to investigate how inflammation leads to bone complications and identify if bone cells drive musculoskeletal pain.
A comprehensive review of global evidence finds that chronic postsurgical pain after caesarean delivery is associated with disruption to daily activities, sleep, mood, energy, and sexual wellbeing in the months and years after giving birth. Chronic pain was found to persistently interfere with general activity, walking, normal work, sl...
A new study found that exercise can significantly reduce acute and chronic pain across various conditions, with shorter-duration programs delivering greater pain reductions. Exercise was associated with substantial reductions in pain, regardless of the type, intensity, or duration of exercise.
Reorganizing large clinics into small teams improves care for patients with chronic disease, reducing costs by lowering hospital stays and specialist visits. Teamlet model patients also receive more frequent screenings and show slight improvements in blood sugar, blood pressure, and cholesterol levels.
Researchers at the University of Warwick have identified TRPM2 as a direct pain transducer that amplifies chronic pain signals. Blocking TRPM2 with a drug injected into the joint completely reversed arthritis pain in mice, providing a promising new approach to treating chronic pain more effectively.
A comprehensive review of 20 years of research involving over 80,000 carers found that many deprioritise and dismiss their own emotional needs, highlighting the need for psychological support-seeking among carers.
A clinical trial found significant improvements in pain and sensation in people with treatment-resistant painful diabetic neuropathy after receiving spinal cord stimulation. The study also observed early evidence of increased density of small nerve fibers in the skin, which may indicate potential long-term benefits.
Researchers discovered that psilocybin prevents nerve injury and associated symptoms in preclinical models, protecting sensory nerve endings and preserving touch sensation. Psilocybin may offer a new intervention for preventing chemotherapy-induced peripheral neuropathy, improving patients' quality of life.
Drexel researchers found converging evidence for three mechanisms that contribute to music-based interventions' effectiveness, including selecting personal music and engaging with it. The study emphasizes the need for more research into music's effects on pain, particularly in individuals with chronic pain.
Researchers discovered a link between chronic pain and altered skull bone marrow activity, indicating a potential therapeutic target for this debilitating health problem. The study suggests that elevated translocator protein in skull bone marrow may be a key factor in chronic pain development.
A new Cochrane review of 8 randomized controlled trials involving over 500 adults found little to no benefit from widely-used back braces in managing chronic low back pain. The research suggested that the use of lumbar supports may be more common in lower-income countries where active treatment alternatives are less accessible.
Researchers at University of Texas MD Anderson Cancer Center found that BRAF plays a key role in developing and maintaining chronic nerve pain caused by nerve damage. Using BRAF inhibitors reduced pain sensitivity in preclinical models, suggesting therapeutic potential for treating chronic nerve pain.
Researchers found that tumors can damage peripheral nerves before chemotherapy begins, leading to potential nerve damage and chronic pain. The study challenges the conventional thought that peripheral neuropathy is mostly due to chemotherapy treatment.
Surzen Biotherapeutics aims to develop effective pain relief without severe side effects by targeting opioid receptor pathways differently. The company plans to use peptides to block dimerization, reducing tolerance and improving efficacy.
Researchers developed a new catheter-based technique to deliver medication directly to the source of severe back pain. Patients reported significant reduction in pain scores and eliminated opioid use after treatment, suggesting potential benefits for patients with refractory thoracolumbar pain.
Exercise produces small improvements in pain and physical function for people with hip osteoarthritis, but those improvements may not be large enough to make a meaningful difference in daily life. Quality of life showed little to no improvement with exercise.
Researchers have developed a new assessment tool to standardize reporting of transcranial magnetic stimulation (TMS) studies. The Transcranial Magnetic Stimulation Reporting Assessment Tool (TMS-RAT) helps compare results, build on each other's findings, and support progress in brain stimulation research. This tool addresses the need f...
A new review of existing research found that AI-based nursing interventions can identify patients at greater risk of complications, reducing unplanned hospital visits and potentially lowering healthcare costs. However, there is a need for further research on the impact of AI on patients' emotional well-being.
A new study from Boston Medical Center found that a group mindfulness program can effectively treat chronic low back pain. Participants showed significant improvements to pain and daily functioning after the program, with gains sustained at a 12-month follow-up.
A study from the University of Gothenburg found that patients with chronic pain do not have equal access to specialized rehabilitation programs. Sociodemographic factors such as education, age, sex, and region of birth play a significant role in determining participation rates. The study suggests that addressing these disparities is cr...
A recent study found that self-directed cognitive behavioral therapy for chronic pain (CBT-CP) resulted in modest improvements in pain interference, sustained over 12 months. Additionally, self-directed CBT showed higher session-completion rates compared to clinician-delivered CBT-CP.
Researchers have found a widely available drug combination to be an effective treatment for patients with systemically active Sjögren's disease. The combination of leflunomide and hydroxychloroquine reduced disease activity while maintaining a favorable safety profile.
A five-minute session of proximal intercessory prayer significantly reduced pain and anxiety in primary care patients compared to a music control group. The study suggests that in-person intercessory prayer may offer a practical complement to conventional care for underserved populations.
A University of Reading research team is developing a potential treatment for chronic nerve pain using tiny stem cell particles. The RESOLVE project aims to reduce inflammation and reset the processes that drive long-lasting pain, offering a different approach to current treatments.
A new study by researchers at the University of Toronto identified a specific brain pathway through which cholecystokinin (CCK) acts to amplify pain in response to negative expectations. This pathway, traveling from the anterior cingulate cortex to the lateral periaqueductal gray, increases pain sensitivity and worsens symptoms.
A widely used depression screening questionnaire is accurate for both people with and without chronic pain, according to a new study. The study debunks the myth that screening inflates depression scores for those with chronic pain, which can be masked by fatigue and sleep disturbances.
A new study suggests that ultrasound stimulation can bring about functionally meaningful changes in pain perception and brain connectivity. The research found a delayed analgesic effect, with participants reporting reduced pain intensity after 28-55 minutes following TUS application.
A multi-institutional team led by Sanford Burnham Prebys aims to develop a non-opioid pain therapeutic using lead molecule SBI-810. The effort, funded by a $3.9 million NIH grant, seeks to optimize the compound into a drug that could provide effective pain relief without addiction risks.
The article discusses how emerging digital tools are capturing the biopsychosocial reality of chronic pain. Digital tools such as wearables, AI-driven trackers, and ecological momentary assessments mitigate recall bias by recording data in real-time, providing a more holistic picture of the patient's journey.
A new study by University College London found that gabapentinoids, prescribed for chronic pain, double the risk of hospitalization for drug poisoning when combined with benzodiazepines or opioids. The risk persists even after starting gabapentinoid treatment, suggesting they may not be an effective solution to reduce poisoning risks.
Researchers have created a high-resolution molecular map of specific sensory neurons that trigger pain, revealing two subtypes of nociceptors with distinct functional components. The study provides insights into the molecular mechanisms of chronic inflammatory pain and identifies potential new drug targets using Deep Visual Proteomics.
A randomized trial found that duloxetine does not prevent painful neuropathy caused by oxaliplatin-based chemotherapy in patients with stage II or III colorectal cancer. The study suggests that duloxetine should only be used for managing existing neuropathy, not prevention.
A recent study found a decline in long-term opioid prescribing in the US between 2015 and 2023, with a 24.3% decrease in patients receiving extended therapy. However, approximately 4.2 million US patients still received opioids for 90 days or longer in 2023, indicating the need for improved treatment models for chronic pain management.
A new study found that male, married Canadians with social support, healthy habits, and excellent health are more likely to experience high levels of emotional, psychological, and social well-being. Social support was a key factor associated with flourishing mental health among older adults.
Researchers have mapped a brain circuit specific to chronic pain, suggesting a promising route to treatment. Silencing this circuit eased chronic pain while preserving acute pain responses in mice. The discovery raises the possibility of developing drugs that target this circuit to ease chronic pain without impacting acute pain.
A new study led by University of Iowa Health Care researchers found that TENS reduced movement-evoked pain and fatigue in patients with fibromyalgia, with effects lasting for at least six months. The treatment was also shown to be safe, effective, inexpensive, and readily available.
A Concordia-led study reveals that many Canadian surgery residents scored below the threshold of adequate pain knowledge, with limited grasp of the biopsychosocial model and unpreparedness to treat pain in children. This highlights the need for improved medical training to address this critical gap.
Research suggests that persistent pain drives progressive changes in the hippocampus, a brain region involved in emotional regulation. This can shape whether people develop depression or remain emotionally resilient. The study's findings challenge the idea that depression is an inevitable consequence of long-term pain.
A new study from Dartmouth College finds that social information can significantly impact how people experience negative events, including physical pain and mentally demanding tasks. When others describe an experience as painful, individuals tend to feel it that way, even when the actual experience is low in intensity.
A team of researchers has developed a method to decode fluctuations in spontaneous pain intensity in individuals with chronic pain using extensively sampled functional MRI data. The study found that neural patterns underlying pain differ markedly between individuals, highlighting the importance of individualized brain-based biomarkers.
A new study from CU Anschutz links chronic back pain to heightened brain responses to everyday sounds and finds that Pain Reprocessing Therapy can improve sensory amplification. The research found specific brain changes associated with sound hypersensitivity, which can be treated with psychological therapy.
The UT Health San Antonio School of Dentistry has secured a $9 million NIH grant to develop a targeted, non-opioid treatment for chronic pain associated with muscle and joint dysfunction. Researchers will map the biology of facial pain, identify specialized neurons, and analyze gene expression changes to design effective treatments.
A study reveals that two key proteins, TSP1 and TSP2, play a central role in shaping the healing environment after injury, leading to abnormal bone growth. The findings suggest targeting these proteins may reduce harmful bone formation without interfering with healthy development.
Researchers found that hormone treatment reduces abnormal nerve invasion and improves chronic back pain by limiting nerve growth inside damaged spinal tissue. The study suggests that parathyroid hormone can reverse the process by activating natural signals.
Researchers have discovered a neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into chronic pain. Silencing this pathway can prevent or halt chronic pain, offering new hope for treating severe chronic pain with injections or infusions targeting specific brain cells.
An updated Cochrane review of 21 clinical trials involving over 2,100 adults found no high-quality evidence that cannabis-based medicines reduce neuropathic pain more than placebo. Small improvements were reported by patients using products with both THC and CBD, but these changes were not clinically meaningful.
A new study from Murdoch University found that 66% of participants with Complex Regional Pain Syndrome (CRPS) experienced migraines that started or worsened after CRPS onset. This research highlights the connection between CRPS and migraine, suggesting a possible common cause for both conditions.
Researchers at MD Anderson have made significant advancements in cancer treatment, demonstrating the effectiveness of immunotherapy before and after surgery in improving lung cancer patient outcomes. Additionally, a new study shows promise in using CAR T cell therapy to treat large B-cell lymphoma, reducing relapse rates.
Two new studies found that around 1 in 8 day-case surgery patients are admitted to hospital for complications, while 1 in 14 develop chronic pain at the operative site. Chronic post-surgical pain is more common in certain procedures and among patients with medical problems, with orthopaedic and breast surgeries showing higher rates.
A recent study found that back pain can predict sleep problems years later in men over 65, leading to a 12% to 25% increase in sleep issues. Men with back pain are more likely to experience poor sleep quality and daytime sleepiness.
A systematic evidence review finds that cannabis products with higher levels of THC provide short-term pain relief, but at the cost of increased side effects. CBD-based products, on the other hand, show almost no benefit in reducing pain.
Estrogen activates previously unknown pathways in the colon, triggering pain and increasing sensitivity to certain foods. This explains why women are more likely to suffer from IBS and provides potential new ways to treat the condition.
Research reveals cannabis use may promote deep, restorative sleep critical for physical restoration and immune function, but at the cost of reduced emotional regulation and memory integration. Chronic cannabis users experience diminishing benefits as use increases.
Chronic pain prevalence differs between rural and urban adult cancer survivors, with rural areas showing higher rates despite having fewer resources. Limited access to pain specialists and insurance challenges contribute to these disparities.
A cohort study found that participation in New York's medical cannabis program was associated with lower rates of opioid prescription during a 18-month follow-up. The study controlled for unregulated cannabis use, suggesting that medical cannabis may be an effective alternative to opioids for managing chronic pain.
A new study published in JAMA Internal Medicine found that adults with chronic pain who used medical cannabis had a 22% reduction in opioid use. The study, led by researchers at Albert Einstein College of Medicine, suggests that supervised use of medical cannabis can relieve chronic pain and reduce reliance on prescription opioids.
A recent study found that only one-third of patients with sickle cell disease received guideline-adherent pain treatment within the first hour at emergency departments. The study analyzed data from over 398,000 visits and found disparities in treatment based on age, sex, and insurance status.
Researchers have identified a previously unknown sodium-binding site on GlyT2, which supplies the energetic drive required for glycine transport. The study also uncovered a distinctive allosteric binding pocket for lipid-based inhibitors, providing a foundation for rational design of improved analgesics.
Researchers tracked 120 older veterans taking gabapentinoids and loop diuretics, finding that only 4 doctors correctly identified the gabapentinoids as the cause of leg swelling. The study highlights the dangers of 'prescribing cascades' and emphasizes the need for regular monitoring and alternative treatment options.